Nuclear localisation of p65 in sputum macrophages but not in sputum neutrophils during COPD exacerbations

Thorax

Volumn 58, Issue 4, 2003, Pages 348-351

  Caramori, G ^a   Romagnoli, M ^c   Casolari, P ^a   Bellettato, C ^a   Casoni, G ^a   Boschetto, P ^a   Fan Chung, K ^b   Barnes, P J ^b   Adcock, I M ^b   Ciaccia, A ^a   Fabbri, L M ^c   Papi, A ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^c UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; SYNAPTOTAGMIN;

AGED; ARTICLE; CELL COUNT; CELL NUCLEUS; CELLULAR DISTRIBUTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; INFLAMMATORY CELL; LUNG FUNCTION TEST; LUNG PARENCHYMA; MACROPHAGE; MALE; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SMOKING; SPUTUM ANALYSIS;

AGED; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CALCIUM-BINDING PROTEINS; CELL NUCLEUS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MACROPHAGES; MALE; MEMBRANE GLYCOPROTEINS; NERVE TISSUE PROTEINS; NEUTROPHILS; NF-KAPPA B; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SPUTUM; SYNAPTOTAGMIN I; SYNAPTOTAGMINS;

EID: 0037383155     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thorax.58.4.348     Document Type: Article

References (11)

1. National Institutes of Health, National Heart, Lung and Blood Institute. Global initiative for chronic obstructive lung disease (GOLD). Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease, NHLBI/WHO workshop report. NIH Publication No 2701A. Bethesda, MD: NIH/NHLBI, 2001.
2. Saetta M, Turato G, Maestrelli P, et al. Cellular and structural bases of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;163:1304-9.
3. Barnes P J. Chronic obstructive pulmonary disease. N Engl J Med 2000;343:269-80.
4. Barnes P J, Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997;336:1066-71.
5. Bhowmik A, Seemungal TA, Sapsford RJ, et al. Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations. Thorax 2000;55:114-20.
6. Papi A, Romagnoli M, Baraldo S, et al. Partial reversibility of airflow limitation and increased exhaled NO and sputum eosinophilia in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000;162:1773-7.
7. Hoshi H, Ohno I, Honma M, et al. IL-5, IL-8 and GM-CSF immunostaining of sputum cells in bronchial asthma and chronic bronchitis. Clin Exp Allergy 1995;25:720-8.
8. Usmani OS, Maneechotesuwan K, Tomita K, et al. Glucocorticoid receptor immunolocalisation in sputum cells. Am J Respir Crit Care Med 2001;163(Suppl):abstract A230.
9. Carter AB, Monick MM, Hunninghake GW. Lipopolysaccharide-induced NF-κB activation and cytokine release in human alveolar macrophages is PKC-independent ad TK- and PC-PLC-dependent. Am J Respir Cell Mol Biol 1998;18:384-91.
10. Sethi S, Evans N, Grant BJB, et al. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. N Engl J Med 2002;347:465-71.
11. McDonald PP, Bald A, Cassatella MA. Activation of the NF-κB pathway by inflammatory stimuli in human neutrophils. Blood 1997;89:3421-33.